Skip to main content

Table 2 Study I echocardiography

From: Systemic and cardiac susceptibility of immune compromised mice to doxorubicin

  

2 weeks

BASELINE

CONTROL

DOXORUBICIN

Parameter

Unit

MEAN

SE

MEAN

SE

MEAN

SE

LVAW;d

mm

0.83

0.04

0.83

0.04

0.99*

0.15

LVAWS;s

mm

1.08

0.06

1.10

0.04

1.33*

0.15

LVID;d

mm

3.25

0.08

3.59

0.11

2.64*

0.22

LVID;s

mm

2.16

0.08

2.55

0.14

1.53*

0.24

LVPW;d

mm

0.79

0.05

0.92

0.08

1.04*

0.07

LVPW;s

mm

1.00

0.05

1.08

0.04

1.26*

0.11

Cardiac Output

ml/min

11.94

0.91

14.71

1.30

6.82*

1.32

Ejection Fraction

%

67.72

1.78

57.87

3.73

76.10

6.35

Fractional Shortening

%

36.94

1.33

30.05

2.51

45.31

6.28

Heart Rate

BPM

381

18

471

21

352

23

Stroke Volume

ul

30.62

1.56

31.30

2.33

18.91*

3.18

Volume;d

ul

45.62

2.74

54.64

4.53

26.40*

5.53

Volume;s

ul

15.00

1.47

23.34

3.47

7.49*

2.86

 

N = 8 m, 4f

N = 4 m, 2f

N = 4 m, 2f

  1. LV left ventricle, AW anterior wall, ID internal diameter, PW posterior wall, d diastolic, s systolic, BPM beats per minute. *p < 0.05 repeated measures ANOVA